Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
D. Agapakis, D. Tsantilas, P. Psarris, E. Massa, P. Kotsaftis, K. Tziomalos, A. Hatzitolios (Thessaloniki, Greece). Contribution of AT-III and protein-C to the assessment of severity of community-acquired pneumonia. Eur Respir J 2010; 36: Suppl. 54, 2220

Member's Comments

No comment yet.

Related content which might interest you: Value of hypoalbuminemia as a sign of severity of community-acquired pneumonia Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication Year: 2007 Usefulness of shock index in severity assessment of community-acquired pneumonia Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections Year: 2007 Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Biomarkers and severity in community-acquired pneumonia (CAP) Source: Annual Congress 2012 - Prognostic indices in respiratory infections Year: 2012 Severe community-acquired pneumonia Source: Eur Respir Monogr 2016; 74: 101-116 Year: 2016 Usefulness of serum cortisol in assessment for the severity of community-acquired pneumonia Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia Year: 2011 Community-acquired pneumonia (CAP): evaluation of severity criteria for hospitalization Source: Eur Respir J 2003; 22: Suppl. 45, 335s Year: 2003 D-dimer elevation is associated with severity of community-acquired pneumonia according to CURB-65 and PSI Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia Year: 2006 Biomarkers and clinical stability in community-acquired pneumonia Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 Severity assessment of healthcare-associated pneumonia and pneumonia in immunosuppression Source: Eur Respir J 2012; 40: 1201-1210 Year: 2012 Assessment of urinary pneumococcal antigen for etiological diagnosis of community-acquired pneumonia Source: Annual Congress 2003 - New aspects of community acquired pneumonia Year: 2003 Predicting severe sepsis in community-acquired pneumonia using CURB65 and PSI scores Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections Year: 2008 Relationship between etiologic diagnosis and prognosis in community-acquired pneumonia Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015 Role of procalcitonin in predicting severity and in-hospital mortality in patients with community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 C-reactive protein in community-acquired pneumonia Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia Year: 2006 Impact of aspiration pneumonia in community-acquired pneumonia and healthcare-associated pneumonia Source: Annual Congress 2012 - CT findings: educational posters Year: 2012 Pulmonary tuberculosis in the differential diagnosis of community-acquired pneumonia Source: Eur Respir J 2012; 40: 279 Year: 2012 Clinical failure in community-acquired pneumonia Source: International Congress 2014 – PG16 Low respiratory tract infections: learning from real clinical cases Year: 2014 Preventing community-acquired pneumonia Source: International Congress 2019 – Respiratory infections: prevention is better than cure Year: 2019